Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore
Polygon, Standard Chartered Enlisted for AlloyX Tokenized Money Market Fund

Polygon, Standard Chartered Enlisted for AlloyX Tokenized Money Market Fund

CryptoNewsNetCryptoNewsNet2025/10/02 12:51
By:coindesk.com

AlloyX, a Hong Kong-based stablecoin infrastructure firm, has introduced a tokenized money market fund called RYT, debuted on Ethereum scaling network Polygon with custody services provided by Standard Chartered Bank.

Unlike traditional tokenized money market funds, which offer passive exposure, RYT integrates with decentralized finance (DeFi) to create yield-enhancing strategies, while staying within a compliance framework recognizable to auditors and regulators, AlloyX said in a press release on Thursday.

The stablecoin ecosystem has been growing exponentially over the last few years to a $280 billion market capitalization according to DeFiLlama data. Tether’s USDT and Circle’s USDC remain the dominant stablecoins making up over 80% of the sector.

Last month, AlloyX was acquired by Solowin Holdings (SWIN), a Hong Kong-based, publicly-traded investment holding firm, for $350 million to bolster an expansion into emerging markets.

The deal promises T+1 settlement cycles, which means securities transactions settle one business day after the trade date, and the release of selected fund data on-chain, giving investors greater transparency while keeping operations inside a regulated framework.

Polygon Labs is supporting the rollout with technical integration and ecosystem growth efforts. RYT will remain exclusive to Polygon during its initial launch period before expanding to other networks, the companies said.

“With Polygon-based looping to amplify utility and bank-grade tokenized MMF rails supplying the underlying cash component, RYT aims to bridge DeFi liquidity with a transparent, audited cash management layer—while keeping issuance, custody and reconciliation squarely within a regulated framework,” said Dr. Thomas Zhu, Co-Founder and CEO of AlloyX Group.

0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

PoolX: Earn new token airdrops
Lock your assets and earn 10%+ APR
Lock now!

You may also like

XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

- SEC approves multiple XRP/DOGE ETFs from 21Shares, Franklin Templeton, and Grayscale, signaling growing institutional acceptance of altcoins. - 21Shares' TOXR ETF gains automatic approval via CME CF XRP-Dollar tracking, with Coinbase and BNY Mellon handling custody/admin functions. - Franklin Templeton's XRP Trust removes restrictive clauses to accelerate listing, offering regulated exposure without custody risks from ledger forks. - Grayscale expands crypto offerings with XRP/DOGE ETFs on NYSE, joining

Bitget-RWA2025/11/23 20:48
XRP News Today: SEC Approves Altcoin ETFs, Boosting Institutional Investment in Cryptocurrency

Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

- ECB warns U.S. equity/crypto corrections threaten stability, urging central banks to retain rate-cut flexibility amid market volatility. - JPMorgan links crypto ETF outflows to retail investor behavior, noting $4B November sales contrast with $96B equity ETF inflows. - U.S. Treasury downplays recession risks, citing 2026 growth optimism despite shutdown impacts and services-driven inflation. - MSCI highlights tech valuation risks akin to dot-com era, while DeFi faces $12B liquidity crisis with 95% capita

Bitget-RWA2025/11/23 20:30
Polkadot Latest Updates: ECB Raises Concerns: Cryptocurrency and Stock Market Downturns Resemble Dot-Com Bubble Threats

Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

- Novartis raised 2030 sales growth targets to 5-6% annually, driven by high peak sales expectations for oncology drugs Kisqali and Scemblix. - CEO Vas Narasimhan highlighted eight de-risked drugs with $3-10B peak potential, but analysts warned of patent expirations and uncertain pipeline progress beyond 2030. - Shares rose 0.5% post-announcement, while Exact Sciences surged 17% on its $105/share acquisition by Abbott and Samsung Biologics saw a 71% valuation re-rating after spin-off. - J.P. Morgan caution

Bitget-RWA2025/11/23 20:30
Novartis Increases 2030 Growth Projections Despite Analysts' Concerns About Patent Threats

Institutional Blockchain Integration: Blockdaemon and 21shares Bridge Traditional Finance and Web3 through the Canton Network

- Blockdaemon's Institutional Vault now supports Canton Coin, enabling secure custody and tokenization for institutions on the Canton Network. - 21shares launched a Canton Coin ETP on Euronext, offering investors institutional-grade exposure to privacy-focused blockchain innovation. - Canton Network's architecture, backed by J.P. Morgan and Goldman Sachs , facilitates secure, interoperable transactions while maintaining regulatory compliance. - Partnerships between blockchain infrastructure providers and t

Bitget-RWA2025/11/23 20:30
Institutional Blockchain Integration: Blockdaemon and 21shares Bridge Traditional Finance and Web3 through the Canton Network